Search Results 1291-1300 of 17446 for Cyclophosphamide
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
The purpose of this study is to determine if study drug (BMS-986020) dose of 600 mg once daily or 600 mg twice daily for 26 weeks compared with placebo will ...
Analyzing the genetic makeup of breast cancer cells to understand how DNA changes affect response to cancer treatments and personalize treatment options.
Subject has received previous treatment with lymphocyte-depleting therapies (e.g., Campath™, anti-CD4, cladribine, rituximab, ocrelizumab, cyclophosphamide ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.